Intraperitoneal inoculation of Sandhoff mouse neonates with an HIV-1 based lentiviral vector exacerbates the attendant neuroinflammation and disease phenotype

Stephanos Kyrkanides, Jen nie H. Miller, Ross H. Tallents, Sabine M. Brouxhon, Gina M. Centola, John A. Olschowka

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Abstract

We aimed to evaluate the efficacy of VSV-G pseudotyped, defective HIV-1 based lentiviral vectors for the neonatal transfer of therapeutic genes following systemic administration in Sandhoff mouse pups. Despite transgene expression in mouse brains, these animals presented with significant exacerbation and acceleration of the disease neurological phenotype. We observed an increase and acceleration in the presence of MHC-II and CD45+ cells in their brains, along with neuroinflammation, but not in control heterozygous or wild type littermates that also received the same treatment.

Original languageEnglish
Pages (from-to)39-47
Number of pages9
JournalJournal of Neuroimmunology
Volume188
Issue number1-2
DOIs
StatePublished - Aug 2007

Bibliographical note

Funding Information:
We would like to thank Dr. Richard L. Proia for providing the HexB −/− knockout Sandhoff mice as well as the goat anti-HEXB antibody used in this study. This work was supported in part by a grant from NIH/NINDS number NS048339 awarded to SK.

Keywords

  • Gene therapy
  • Lentiviral vectors
  • Lysosomal storage disorder
  • Sandhoff disease
  • β-hexosaminidase

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Neurology
  • Clinical Neurology

Fingerprint

Dive into the research topics of 'Intraperitoneal inoculation of Sandhoff mouse neonates with an HIV-1 based lentiviral vector exacerbates the attendant neuroinflammation and disease phenotype'. Together they form a unique fingerprint.

Cite this